Chan Kyu Kim

Associate professor

Soonchunhyang University Hospital Bucheon

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Chan Kyu Kim is an Associate Professor at Soonchunhyang University Hospital Bucheon, South Korea. His research interests include hematopoietic stem cell transplantation, immunotherapy, and the clinical outcomes of patients with hematological malignancies. Dr. Kim has contributed significantly to the understanding of treatment modalities for elderly patients, as well as the management of metastatic cancers, through his recent publications in leading medical journals.

Articles (10)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Jina Yun

Associate Professor

Soonchunhyang University Hospital Bucheon

SOUTH KOREA

View details

Seong Kyu Park

Professor

Soonchunhyang University Hospital Bucheon

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chan Kyu Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea

Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?

Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine

TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy

Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial

2020 Korean guidelines for the management of metastatic prostate cancer

Tet2 mutation and high mir-22 expression as biomarkers to predict clinical outcome in myelodysplastic syndrome patients treated with hypomethylating therapy

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities

Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?

Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D,cyclophosphamide, and vincristine: A case report

Collaborators (2)

Jina Yun

Seong Kyu Park

Make your next move.